Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990766 · ClinicalTrials.gov registry record · Phase 2
Smell Changes & Efficacy of Nasal Theophylline
A Phase 2 study of Viral Infection and Anosmia, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03990766 is a Phase 2 study of Viral Infection and Anosmia that has completed, run by Washington University School of Medicine. The registered enrollment target is 27 participants, below the 227-participant average among 11 other Viral Infection trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03990766, a Phase 2 study of Viral Infection and Anosmia, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the efficacy and safety of nasal theophylline irrigation in treating smell loss related to a viral respiratory infection. Half the participants will undergo nasal theophylline irrigation treatment while the other half will undergo placebo nasal irrigation with saline alone. All participants will have their sense of smell tested before and after 6 weeks of treatment. All participants will also be regularly asked about any potential side effects related to treatment. In addition, the first 10 participants will have their blood drawn to measure their theophylline level after 1 week of starting treatment to ensure it is not abnormally elevated.
Conditions Studied
Interventions
- DRUG Theophylline
- DRUG Saline Nasal
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2021-01-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03990766
The ClinicalTrials.gov registry entry for NCT03990766 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 11 other Viral Infection trials with a reported enrollment target (88% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Viral Infection appearing as the primary indexed condition, and to 2 interventions - of which Theophylline is the first listed.
NCT03990766 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03990766 about?
NCT03990766 is a clinical study titled "Smell Changes & Efficacy of Nasal Theophylline". This study evaluates the efficacy and safety of nasal theophylline irrigation in treating smell loss related to a viral respiratory infection. Half the participants will undergo nasal theophylline irrigation treatment while the other half will undergo placebo nasal irrigation with saline alone. All ...
What is the current status of trial NCT03990766?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2019-05-15. Estimated completion is 2021-01-15.
What conditions does trial NCT03990766 study?
This clinical trial studies the following conditions: Viral Infection, Anosmia, Olfactory Disorder, Theophylline Causing Adverse Effects in Therapeutic Use, Smell Disorder.
What interventions are being tested in trial NCT03990766?
The interventions under investigation include: Theophylline (DRUG), Saline Nasal (DRUG).
Who is sponsoring clinical trial NCT03990766?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03990766 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Viral Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Third Party Viral Specific T-cells (VSTs)
RECRUITING · Phase 2
-
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RECRUITING · Phase 2
-
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
ACTIVE NOT RECRUITING · Phase 2
-
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RECRUITING · Phase 1
-
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
RECRUITING · Phase 1
-
School Inner City Air Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.